Lone Pine Capital Cut Facebook (FB) Position by $193.08 Million; First Financial Has Cut Its Abbvie (ABBV) Stake by $869,616; Market Valuation Rose

March 5, 2018 - By Nellie Frank

Stephen Mandel decreased its stake in Facebook Inc (FB) by 18.41% based on its latest 2017Q3 regulatory filing with the SEC. Lone Pine Capital Llc sold 1.14 million shares as the company’s stock rose 10.88% with the market. The hedge fund run by Stephen Mandel held 5.03 million shares of the technology company at the end of 2017Q3, valued at $859.86M, down from 6.17M at the end of the previous reported quarter. Lone Pine Capital Llc who had been investing in Facebook Inc for a number of months, seems to be less bullish one the $524.61 billion market cap company. The stock increased 2.25% or $3.97 during the last trading session, reaching $180.59. About 14.03 million shares traded. Facebook, Inc. (NASDAQ:FB) has risen 26.75% since March 5, 2017 and is uptrending. It has outperformed by 10.05% the S&P500.

First Financial Corp decreased its stake in Abbvie Inc (ABBV) by 42% based on its latest 2017Q3 regulatory filing with the SEC. First Financial Corp sold 9,882 shares as the company’s stock rose 6.17% with the market. The institutional investor held 13,644 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $1.21 million, down from 23,526 at the end of the previous reported quarter. First Financial Corp who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $184.24B market cap company. The stock increased 0.85% or $0.98 during the last trading session, reaching $116.02. About 2.99M shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since March 5, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Since September 5, 2017, it had 0 insider purchases, and 37 insider sales for $838.24 million activity. The insider Zuckerberg Mark sold $42.50M. On Wednesday, February 14 the insider Sandberg Sheryl sold $9.75M. On Thursday, September 21 Cox Christopher K sold $2.73 million worth of Facebook, Inc. (NASDAQ:FB) or 16,000 shares. FISCHER DAVID B. sold $3.29 million worth of stock. On Thursday, February 15 the insider Schroepfer Michael Todd sold $4.82 million. $221.33 million worth of stock was sold by Koum Jan on Thursday, February 15.

Investors sentiment decreased to 1.15 in 2017 Q3. Its down 0.25, from 1.4 in 2017Q2. It is negative, as 53 investors sold FB shares while 618 reduced holdings. 128 funds opened positions while 644 raised stakes. 1.63 billion shares or 0.88% more from 1.62 billion shares in 2017Q2 were reported. Bb&T Secs Lc stated it has 0.39% of its portfolio in Facebook, Inc. (NASDAQ:FB). Hound Ptnrs Llc invested 2.72% in Facebook, Inc. (NASDAQ:FB). Marsico Capital Mngmt Lc holds 806,601 shares or 5.53% of its portfolio. Cambridge Financial Grp reported 42,021 shares. 12,821 are held by Tower Capital Ltd Liability Corporation (Trc). 244 were accumulated by Exchange Cap Mgmt. Capstone Investment Advsrs Llc owns 4,600 shares for 0.03% of their portfolio. Natixis Asset owns 105,921 shares for 1.57% of their portfolio. Advisor Prtnrs Limited Liability Corp has invested 1.32% of its portfolio in Facebook, Inc. (NASDAQ:FB). Paradigm Asset Management Communications accumulated 0.1% or 2,350 shares. 2,896 are held by Mechanics Comml Bank Department. Pure Incorporated holds 0.09% of its portfolio in Facebook, Inc. (NASDAQ:FB) for 1,945 shares. Tarbox Family Office reported 1,671 shares or 0.13% of all its holdings. Waratah Cap Ltd invested in 3.13% or 144,171 shares. Kames Pcl owns 4.5% invested in Facebook, Inc. (NASDAQ:FB) for 962,066 shares.

Lone Pine Capital Llc, which manages about $34.98 billion and $20.57 billion US Long portfolio, upped its stake in Servicenow Inc (NYSE:NOW) by 2.05 million shares to 5.27M shares, valued at $619.57 million in 2017Q3, according to the filing. It also increased its holding in Advance Auto Parts Inc (NYSE:AAP) by 310,065 shares in the quarter, for a total of 2.36M shares, and has risen its stake in Grupo Televisa Sa (NYSE:TV).

Analysts await Facebook, Inc. (NASDAQ:FB) to report earnings on May, 2. They expect $1.40 earnings per share, up 34.62% or $0.36 from last year’s $1.04 per share. FB’s profit will be $4.07 billion for 32.25 P/E if the $1.40 EPS becomes a reality. After $2.20 actual earnings per share reported by Facebook, Inc. for the previous quarter, Wall Street now forecasts -36.36% negative EPS growth.

Among 54 analysts covering Facebook (NASDAQ:FB), 50 have Buy rating, 2 Sell and 2 Hold. Therefore 93% are positive. Facebook had 236 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by M Partners with “Buy” on Friday, May 13. The stock of Facebook, Inc. (NASDAQ:FB) has “Buy” rating given on Thursday, November 2 by Jefferies. Monness Crespi & Hardt upgraded the shares of FB in report on Friday, October 27 to “Buy” rating. Argus Research maintained the shares of FB in report on Friday, November 6 with “Buy” rating. The stock of Facebook, Inc. (NASDAQ:FB) has “Buy” rating given on Monday, January 8 by Credit Suisse. The rating was maintained by Stifel Nicolaus with “Buy” on Thursday, January 28. The firm has “Outperform” rating given on Thursday, April 28 by Oppenheimer. The firm has “Buy” rating given on Thursday, February 2 by Mizuho. The company was maintained on Wednesday, September 6 by KeyBanc Capital Markets. The firm has “Buy” rating by Brean Capital given on Thursday, July 30.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 9 Hold. Therefore 48% are positive. Abbvie Inc had 79 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Hold” rating by BMO Capital Markets given on Wednesday, June 7. The stock of AbbVie Inc. (NYSE:ABBV) earned “Outperform” rating by Leerink Swann on Monday, October 30. The firm has “Buy” rating given on Wednesday, July 22 by SunTrust. The stock of AbbVie Inc. (NYSE:ABBV) has “Buy” rating given on Monday, February 26 by Jefferies. The firm has “Equal-Weight” rating by Barclays Capital given on Friday, October 13. UBS maintained AbbVie Inc. (NYSE:ABBV) on Friday, October 13 with “Neutral” rating. The firm has “Buy” rating by Jefferies given on Friday, July 14. The firm has “Sell” rating by Societe Generale given on Wednesday, April 6. As per Friday, September 15, the company rating was maintained by Piper Jaffray. The stock of AbbVie Inc. (NYSE:ABBV) earned “Hold” rating by Deutsche Bank on Tuesday, March 15.

Investors sentiment decreased to 0.85 in 2017 Q3. Its down 0.15, from 1 in 2017Q2. It is negative, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. Manufacturers Life The reported 3.19M shares. Riggs Asset Managment holds 0% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 46 shares. Hightower Advsrs Ltd Limited Liability Company reported 562,524 shares. Epoch Invest Ptnrs Inc has 7.87M shares for 2.34% of their portfolio. Forbes J M & Co Llp has invested 2.11% in AbbVie Inc. (NYSE:ABBV). Smith Moore And stated it has 28,731 shares. Hartford Financial Management Inc stated it has 0.01% in AbbVie Inc. (NYSE:ABBV). Princeton Strategies Limited Company reported 2.71% stake. Bridges Investment has 45,999 shares for 0.53% of their portfolio. Wendell David Assocs owns 120,093 shares. Dumont Blake Invest Advisors Ltd Liability Corporation has invested 0.89% of its portfolio in AbbVie Inc. (NYSE:ABBV). State Of Wisconsin Board accumulated 1.62M shares. Texas-based Linscomb And Williams has invested 0.48% in AbbVie Inc. (NYSE:ABBV). Haverford Tru has invested 0.17% in AbbVie Inc. (NYSE:ABBV). Rafferty Asset Management Ltd stated it has 0.09% of its portfolio in AbbVie Inc. (NYSE:ABBV).

Since September 11, 2017, it had 0 insider buys, and 6 insider sales for $25.71 million activity. SALEKI-GERHARDT AZITA also sold $705,655 worth of AbbVie Inc. (NYSE:ABBV) on Monday, September 11. 87,040 AbbVie Inc. (NYSE:ABBV) shares with value of $8.57M were sold by RICHMOND TIMOTHY J.. On Monday, October 30 Gosebruch Henry O sold $1.66M worth of AbbVie Inc. (NYSE:ABBV) or 18,300 shares. On Thursday, December 14 the insider Schumacher Laura J sold $14.07M.